BioCentury
ARTICLE | Distillery Therapeutics

Antibody-drug conjugate targeting CLDN6 for liver cancer

February 26, 2021 10:14 PM UTC

DISEASE CATEGORY: Cancer

INDICATION: Liver cancer...

BCIQ Company Profiles

Guangzhou Medical University

BCIQ Target Profiles

Claudin 6 (CLDN6)